4.8 Article

Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes

期刊

NUCLEIC ACIDS RESEARCH
卷 38, 期 -, 页码 D670-D675

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkp957

关键词

-

资金

  1. Associazione Italiana Ricerca sul Cancro
  2. Fondazione Cariplo

向作者/读者索取更多资源

The Network of Cancer Genes (NCG) collects and integrates data on 736 human genes that are mutated in various types of cancer. For each gene, NCG provides information on duplicability, orthology, evolutionary appearance and topological properties of the encoded protein in a comprehensive version of the human protein-protein interaction network. NCG also stores information on all primary interactors of cancer proteins, thus providing a complete overview of 5357 proteins that constitute direct and indirect determinants of human cancer. With the constant delivery of results from the mutational screenings of cancer genomes, NCG represents a versatile resource for retrieving detailed information on particular cancer genes, as well as for identifying common properties of precompiled lists of cancer genes. NCG is freely available at: http://bio.ifom-ieo-campus.it/ncg.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Oncology

Normal Somatic Mutations in Cancer Transformation

Neshika Wijewardhane, Lisa Dressler, Francesca D. Ciccarelli

Summary: Gene alterations play a crucial role in driving cancer initiation and progression, but the genetic events occurring in normal cells prior to tumorigenesis remain unknown. Recent studies have started mapping somatic mutations in normal human tissues, shedding light on our understanding of tumorigenesis.

CANCER CELL (2021)

Article Genetics & Heredity

Identification of rare and common regulatory variants in pluripotent cells using population-scale transcriptomics

Marc Jan Bonder, Craig Smail, Michael J. Gloudemans, Laure Fresard, David Jakubosky, Matteo D'Antonio, Xin Li, Nicole M. Ferraro, Ivan Carcamo-Orive, Bogdan Mirauta, Daniel D. Seaton, Na Cai, Dara Vakili, Danilo Horta, Chunli Zhao, Diane B. Zastrow, Devon E. Bonner, Matthew T. Wheeler, Helena Kilpinen, Joshua W. Knowles, Erin N. Smith, Kelly A. Frazer, Stephen B. Montgomery, Oliver Stegle

Summary: By integrating data from 1,367 human iPSC lines, researchers comprehensively mapped common and rare regulatory variants in human pluripotent cells, identified new colocalization events specific to iPSCs, and demonstrated the utility of iPSCs in identifying causal genes for rare diseases.

NATURE GENETICS (2021)

Article Genetics & Heredity

Pan-cancer detection of driver genes at the single-patient resolution

Joel Nulsen, Hrvoje Misetic, Christopher Yau, Francesca D. Ciccarelli

Summary: sysSVM2 is a machine learning software that integrates cancer genetic alterations with gene systems-level properties to predict driver genes in individual patients, showing low false-positive rate and stability, with applicability to rare cancer types. It can be used to identify driver alterations in patients lacking sufficient canonical drivers, furthering the goals of precision oncology.

GENOME MEDICINE (2021)

Article Multidisciplinary Sciences

Enhancer release and retargeting activates disease-susceptibility genes

Soohwan Oh, Jiaofang Shao, Joydeep Mitra, Feng Xiong, Matteo D'Antonio, Ruoyu Wang, Ivan Garcia-Bassets, Qi Ma, Xiaoyu Zhu, Joo-Hyung Lee, Sreejith J. Nair, Feng Yang, Kenneth Ohgi, Kelly A. Frazer, Zhengdong D. Zhang, Wenbo Li, Michael G. Rosenfeld

Summary: The study shows that when a preferred promoter is functionally lost, its partner enhancer may be released and activate another nearby promoter. This process of target-switching may be determined by CTCF binding at promoters, in line with the model of 'enhancer scanning'. Additionally, the mechanism of enhancer release and retargeting is found to underlie the activation of disease-susceptibility genes.

NATURE (2021)

Article Multidisciplinary Sciences

A SIMPLI (Single-cell Identification from MultiPLexed Images) approach for spatially-resolved tissue phenotyping at single-cell resolution

Michele Bortolomeazzi, Lucia Montorsi, Damjan Temelkovski, Mohamed Reda Keddar, Amelia Acha-Sagredo, Michael J. Pitcher, Gianluca Basso, Luigi Laghi, Manuel Rodriguez-Justo, Jo Spencer, Francesca D. Ciccarelli

Summary: SIMPLI is a flexible and technology-agnostic software for multiplexed imaging data analysis, allowing single-cell analysis and quantification of marker expression while preserving spatial information. Its customizability and parallel processing capabilities make it suitable for large datasets.

NATURE COMMUNICATIONS (2022)

Article Oncology

Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells

Nicola Lockwood, Silvia Martini, Ainara Lopez-Pardo, Katharina Deiss, Hendrika A. Segeren, Robert K. Semple, Ian Collins, Dimitra Repana, Mathias Cobbaut, Tanya Soliman, Francesca Ciccarelli, Peter J. Parker

Summary: G2 arrest is crucial for the faithful segregation of sister chromatids, and the p53-p21 signaling pathway plays an essential role in cell lines, patient-derived cells, and colorectal cancer organoids. In arrest-defective hTERT-positive cells, the PKC epsilon failsafe mechanism is engaged. In ALT-dependent cancer cells, a distinct form of p53-independent G2 arrest is mediated by BLM and Chk1.

CANCER RESEARCH (2022)

Review Cell Biology

Reflected stemness as a potential driver of the tumour microenvironment

Felipe S. Rodrigues, Francesca D. Ciccarelli, Ilaria Malanchi

Summary: The activation of developmental programmes by mutant cells is a fundamental requirement for cancer initiation. Oncogenic signals confer undifferentiated, stem cell-like properties to cancer cells, supporting their long-term proliferative potential. While mutations in cancer-driver genes alone are insufficient for tumor formation, the proliferation of cells with oncogenic mutations depends on their microenvironment. This Opinion article discusses how the reprogrammed status of cancer cells represents their tumorigenicity and triggers 'reflected stemness' in surrounding normal cells, contributing to the establishment of the tumor microenvironment (TME).

TRENDS IN CELL BIOLOGY (2022)

Article Biochemical Research Methods

In heart failure reactivation of RNA-binding proteins is associated with the expression of 1,523 fetal-specific isoforms

Matteo D'Antonio, Jennifer P. Nguyen, Timothy D. Arthur, Hiroko Matsui, Margaret K. R. Donovan, Agnieszka D'Antonio-Chronowska, Kelly A. Frazer

Summary: Reactivation of fetal-specific genes and isoforms occurs during heart failure, suggesting a stricter transcriptional regulation in fetal cardiac tissue.

PLOS COMPUTATIONAL BIOLOGY (2022)

Article Biology

Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas

Alvin Wei Tian Ng, Gianmarco Contino, Sarah Killcoyne, Ginny Devonshire, Ray Hsu, Sujath Abbas, Jing Su, Aisling M. Redmond, Jamie M. J. Weaver, Matthew D. Eldridge, Simon Tavare, Paul A. W. Edwards, Rebecca C. Fitzgerald

Summary: This study categorizes genomic structural variants (SVs) in 383 cases of oesophageal cancer, uncovering mutational patterns and new disease drivers. Identification of SV events in OAC is crucial for targeted therapies.

COMMUNICATIONS BIOLOGY (2022)

Article Oncology

Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway

Jessica Marinello, Andrea Arleo, Marco Russo, Maria Delcuratolo, Francesca Ciccarelli, Yves Pommier, Giovanni Capranico

Summary: This study used molecular, genetic, and bioinformatic approaches to investigate the mechanism of micronuclei formation induced by TOP1 poisons in different cancer cells. The results revealed an immune signaling mechanism activated by TOP1 poisons, which is often impaired in human small-cell lung cancer tumors.

BRITISH JOURNAL OF CANCER (2022)

Review Oncology

Somatic variation in normal tissues: friend or foe of cancer early detection?

A. Acha-Sagredo, P. Ganguli, F. D. Ciccarelli

Summary: Somatic variation is an important factor in cancer initiation and early detection. The extent of somatic variation varies across tissues depending on their intrinsic features and exposure to endogenous and exogenous insults. Mutations in tumor suppressor genes involved in chromatin modification and cell growth signaling are tissue-specific drivers of clonal expansion. Understanding the factors triggering the transformation of somatic variation into malignant clones is crucial for cancer prevention and early detection.

ANNALS OF ONCOLOGY (2022)

Article Multidisciplinary Sciences

Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease

Matteo P. D'Antonio, Jennifer P. D. Nguyen, Timothy D. Arthur, Hiroko A. Matsui, Agnieszka D'Antonio-Chronowska, Kelly A. Frazer

Summary: This study identifies 2,578 eQTLs associated with specific developmental stages, tissues, and cell types using spatiotemporal information of 966 RNA-seq cardiac samples. The colocalization between eQTLs and GWAS signals reveals the impact of genetic variants on cardiac traits and diseases. These findings shed light on the specific effects of cardiac GWAS variants on developmental stages, tissues, and cell types.

NATURE COMMUNICATIONS (2023)

Article Genetics & Heredity

Mechanistic insights into the interactions between cancer drivers and the tumour immune microenvironment

Hrvoje Misetic, Mohamed Reda Keddar, Jean-Pierre Jeannon, Francesca D. D. Ciccarelli

Summary: In this study, the significant interactions between cancer-specific genetic drivers and anti- and pro-tumour features of the tumour immune microenvironment (TIME) were computed using Lasso regularised ordinal regression in 32 cancer types. The functional networks linking specific TIME driver alterations to the associated TIME state were reconstructed for head and neck squamous cancer (HNSC). The study identified 477 TIME drivers that are multifunctional genes, predicted the immune profiles of HNSC molecular subtypes, and provided insights into the immune-regulatory role of TIME drivers.

GENOME MEDICINE (2023)

Article Evolutionary Biology

Exome sequencing of hepatocellular carcinoma in lemurs identifies potential cancer drivers A pilot study

Ella F. Gunady, Kathryn E. Ware, Sarah Hoskinson Plumlee, Nicolas Devos, David Corcoran, Joseph Prinz, Hrvoje Misetic, Francesca D. Ciccarelli, Tara M. Harrison, Jeffrey L. Thorne, Robert Schopler, Jeffrey Everitt, William C. Eward, Jason A. Somarelli

Summary: The mutational landscape of hepatocellular carcinoma in lemurs shows similarities and unique features compared to human hepatocellular carcinomas, suggesting potential differences in the etiology and progression of this cancer in lemurs and humans.

EVOLUTION MEDICINE AND PUBLIC HEALTH (2022)

Article Biotechnology & Applied Microbiology

Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource

Lisa Dressler, Michele Bortolomeazzi, Mohamed Reda Keddar, Hrvoje Misetic, Giulia Sartini, Amelia Acha-Sagredo, Lucia Montorsi, Neshika Wijewardhane, Dimitra Repana, Joel Nulsen, Jacki Goldman, Marc Pollitt, Patrick Davis, Amy Strange, Karen Ambrose, Francesca D. Ciccarelli

Summary: This study compiled a literature-based repertoire of 3355 well-known or predicted drivers of cancer and non-cancer somatic evolution in 122 cancer types and 12 non-cancer tissues. The analysis of these genes revealed that the known compendium of drivers is still incomplete and biased towards frequently occurring coding mutations. There is a high overlap between drivers of cancer and non-cancer somatic evolution, although significant differences exist in their recurrence. Additionally, a set of evolutionarily conserved and essential genes were identified, and alteration in even one of these genes is sufficient to drive clonal expansion but not malignant transformation.

GENOME BIOLOGY (2022)

暂无数据